TrivarX Ltd: June 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Initial Director's Interest Notice - Tony Keating
TrivarX Ltd: Final Director's Interest Notice - Tom Young
TrivarX Ltd: Positive Results from Phase 2 SAMDE Study
TrivarX Ltd: Trading Halt
TrivarX Ltd: Change of Director's Interest Notice - David Trimboli
TrivarX Ltd: Change of Director's Interest Notice - Chris Ntoumenopoulos
TrivarX Ltd: Completion of Phase 2 SAMDE Trial
TrivarX Ltd: TrivarX SAMDE Trial Update
TrivarX Ltd: Investor Webinar
TrivarX Ltd: Trading Halt
TrivarX Ltd: March 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Positive Engagement Meeting with US FDA for MEB-001
TrivarX Ltd: Response to ASX Price Query
TrivarX Ltd: Research Collaboration with Northern Michigan University
TrivarX Ltd: TrivarX Receives $888k R&D Tax Incentive
TrivarX Ltd: TRI-001 Algorithm and Phase 2 Trial Update
TrivarX Ltd: December 2023 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Change of Share Registry Details
TrivarX Ltd: Phase 2 SAMDE Study Update
No Data
No Data